Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Is Kimberly Clark Corp (KMB) The Best Staples Stock to Buy?

Consumer staples stocks are highly regarded by the investing community for the reliability of their profits. It isn’t difficult to understand why. Companies like Kimberly Clark Corp (NYSE:KMB) sell products ranging from paper towels to tissues, products that consumers will purchase regardless of the overall economic climate.

Kimberly Clark Corp (NYSE:KMB)

In addition, consumer staples stocks traditionally distribute a majority of their profits to shareholders via compelling dividend yields. Over the past couple of years, Kimberly Clark has rewarded its investors with not just hefty dividends, but also impressive share price gains. As a result, this begs the question: is Kimberly Clark, the company behind Kleenex, Cottonelle, and Huggies, the best consumer staples stock to buy today? Or is there a more worthy industry peer to consider?

Slow-and-steady stocks that have been anything but

Investing in the consumer staples sector is usually a conversation dominated by dividend payouts, and less so by compelling share price gains. However, notable industry titans including not just Kimberly Clark Corp (NYSE:KMB), but also The Clorox Company (NYSE:CLX), and Colgate-Palmolive Company (NYSE:CL), have soared in price over the past year.

Clorox is an industry leader with many well-known brands. The company sells its products in more than 100 countries, and has many household brands including its namesake bleach, Kingsford charcoal, Pine-Sol cleaner, and Glad trash bags. Nearly 90% of Clorox’s brands hold the No. 1 or No. 2 market-share positions in their categories.

Colgate Palmolive is no slouch. The company is tightly focused on Oral Care, Personal Care, Home Care, and Pet Nutrition. Colgate sells its products in over 200 countries around the world, under such internationally recognized brand names as Colgate, Palmolive, Mennen, Speed Stick, Softsoap, and Irish Spring.

Since these stocks have rallied so much in recent months, their valuations may be a cause for hesitation among investors considering buying shares. Clorox, Kimberly Clark Corp (NYSE:KMB), and Colgate Palmolive trade for 20 times earnings. Colgate-Palmolive’s valuation now exceeds 25 times earnings.

Hefty dividends that will keep coming in for many years

Thankfully, each of these companies has continued to grow dividends at a healthy rate, meaning new investors are still getting market-beating yields. The broader market, as measured by the S&P 500 Index, yields roughly 2%. Kimberly Clark and Clorox both yield 3.3%, while Colgate yields just 2.5% at recent prices, due to its higher multiple.

Moreover, each of these stocks should continue to increase their shareholder payouts for many years to come. As previously mentioned, their stable business models mean steady, reliable growth. In addition, they each have fantastic track records of raising dividends every year, meaning investors now fully expect those streaks to continue.

DOWNLOAD FREE REPORT: Warren Buffett's Best Stock Picks

Let Warren Buffett, George Soros, Steve Cohen, and Daniel Loeb WORK FOR YOU.

If you want to beat the low cost index funds by 19 percentage points per year, look no further than our monthly newsletter.In this free report you can find an in-depth analysis of the performance of Warren Buffett's entire historical stock picks. We uncovered Warren Buffett's Best Stock Picks and a way to for Buffett to improve his returns by more than 4 percentage points per year.

Bonus Biotech Stock Pick: You can also find a detailed bonus biotech stock pick that we expect to return more than 50% within 12 months.
Subscribe me to Insider Monkey's Free Daily Newsletter
This is a FREE report from Insider Monkey. Credit Card is NOT required.